The topical hemostat market size has grown strongly in recent years. It will grow from $5.45 billion in 2025 to $5.97 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to rising prevalence of surgical procedures, demand for rapid hemostasis solutions, technological advancements in biomaterials, increasing hospital surgical capacity, regulatory approvals for hemostatic agents.
The topical hemostat market size is expected to see strong growth in the next few years. It will grow to $8.53 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to growing adoption of bioactive and combination hemostats, integration with AI and digital surgery platforms, expansion of ambulatory surgical centers, focus on patient-specific hemostatic solutions, emerging markets surgical infrastructure growth. Major trends in the forecast period include minimally invasive surgical hemostasis, advanced bioactive hemostats development, patient-specific hemostatic solutions, growth in emergency & trauma care applications, expansion of outpatient & ambulatory surgical procedures.
The rising volume of surgical procedures is anticipated to drive the growth of the topical hemostat market in the coming years. Surgical procedures involve medical interventions performed by surgeons using manual methods and specialized instruments to diagnose, treat, or correct injuries, diseases, or physical abnormalities. The number of surgeries is increasing steadily due to the rapidly aging global population, which has led to a higher prevalence of age-related health conditions that require surgical treatment to enhance quality of life and manage chronic disorders. Topical hemostats are widely used during surgical procedures to enable surgeons to rapidly control bleeding at the surgical site, maintain clear visibility, reduce overall blood loss, and lower the risk of postoperative complications. For instance, in January 2025, according to Intuitive Surgical Inc., a US-based medical device company, OUS general surgery procedures rose by approximately 35% in 2024, following growth of around 42% in 2023. Colorectal procedures represented the largest portion of incremental volume in both years. As a result, the increasing number of surgical procedures is contributing to the expansion of the topical hemostat market.
Key players in the topical hemostat market are concentrating on developing innovative products such as hemostatic sealing patches to improve bleeding control during surgeries by offering faster, more effective, and targeted hemostasis at the wound site. A hemostatic sealing patch is a medical device made from materials like collagen or fibrin that rapidly stops bleeding by adhering to tissue and facilitating clot formation during surgery. For example, in November 2023, Ethicon, Inc., a US-based company specializing in surgical technologies, launched the ETHIZIA Hemostatic Sealing Patch, a new synthetic polymer-based adjunctive hemostat clinically shown to stop severe bleeding on internal organs quickly. In clinical trials, ETHIZIA halted bleeding within 30 seconds in 80% of patients, which is six times faster than leading fibrin sealant patches. The patch is uniquely designed to be effective on both sides and highly adaptable, allowing it to be trimmed, rolled, pulled apart, or customized for use in both open and minimally invasive surgeries. It dehydrates blood and speeds coagulation through a gelatin carrier infused with polyoxazoline polymer, forming a strong adhesive hydrogel that bonds firmly to tissue.
In May 2025, Merit Medical Systems Inc., a US-based global healthcare technology company, acquired BioLife Delaware LLC for approximately $120 million. With this acquisition, Merit seeks to strengthen its bleeding control portfolio by incorporating BioLife’s patented topical hemostatic products, such as StatSeal and WoundSeal, thereby expanding its presence in the topical hemostat market. BioLife Delaware LLC is a US-based manufacturer of hemostatic dressings developed to rapidly control bleeding and minimize complications during interventional and surgical procedures.
Major companies operating in the topical hemostat market are Pfizer Inc, Johnson And Johnson, Medtronic Plc, Medline Industries, Stryker Corporation, Baxter International, Meril Life Sciences Pvt Ltd, Teleflex Incorporated, Samyang Holdings, Integra LifeSciences, B Braun SE, Advanced Medical Solutions Group Plc, Axio Biosolutions, Marine Polymer Technologies Inc, Hangzhou Singclean Medical Products, Neo Modulus Medical Sci-Tech, Tricol Biomedical, HemCon Medical Technologies Inc, Hemostasis LLC, KATSAN Medical Devices, Zhejiang Perfectseal New Materials, Z Medica LLC, Arch Therapeutics Inc, Medcura Inc.
North America was the largest region in the topical hemostat market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the topical hemostat market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the topical hemostat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the topical hemostat market by increasing import costs of raw biomaterials and finished products, particularly affecting fibrin, collagen, and gelatin-based hemostats. Markets in North America and Europe are most impacted due to higher dependency on imported hemostats, while Asia-Pacific manufacturing hubs face fewer direct impacts. Some segments, such as locally produced cellulose and adhesive hemostats, may benefit as tariffs encourage regional sourcing and production. Overall, tariffs are driving manufacturers to optimize supply chains and invest in domestic production to maintain competitiveness.
The topical hemostat market research report is one of a series of new reports that provides topical hemostat market statistics, including topical hemostat industry global market size, regional shares, competitors with a topical hemostat market share, detailed topical hemostat market segments, market trends and opportunities, and any further data you may need to thrive in the topical hemostat industry. This topical hemostat market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A topical hemostat is a specialized medical product applied directly to a bleeding area during surgery or trauma to quickly promote clotting and control bleeding. These agents act locally by forming a physical barrier, triggering the body’s natural clotting processes, or providing a structure that supports platelet clumping and fibrin formation to stop blood flow.
The primary types of topical hemostats include fibrin, thrombin, cellulose, collagen, gelatin, adhesives, and others. Fibrin hemostats are biologically derived agents that replicate the final stages of the coagulation process by combining fibrinogen and thrombin to form a stable clot at the bleeding site. These products are distributed through channels such as direct sales, distributors, hospital pharmacies, and online platforms, and they find application in various surgeries including general, neurosurgery, vascular, and cardiovascular procedures. Key end users comprise hospitals, ambulatory surgical centers, and other healthcare facilities.
The topical hemostat market consists of sales of physical hemostats, active coagulation agents, synthetic and hemisynthetic agents, natural and plant-based agents, and chitosan-based dressings. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The topical hemostat market size is expected to see strong growth in the next few years. It will grow to $8.53 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to growing adoption of bioactive and combination hemostats, integration with AI and digital surgery platforms, expansion of ambulatory surgical centers, focus on patient-specific hemostatic solutions, emerging markets surgical infrastructure growth. Major trends in the forecast period include minimally invasive surgical hemostasis, advanced bioactive hemostats development, patient-specific hemostatic solutions, growth in emergency & trauma care applications, expansion of outpatient & ambulatory surgical procedures.
The rising volume of surgical procedures is anticipated to drive the growth of the topical hemostat market in the coming years. Surgical procedures involve medical interventions performed by surgeons using manual methods and specialized instruments to diagnose, treat, or correct injuries, diseases, or physical abnormalities. The number of surgeries is increasing steadily due to the rapidly aging global population, which has led to a higher prevalence of age-related health conditions that require surgical treatment to enhance quality of life and manage chronic disorders. Topical hemostats are widely used during surgical procedures to enable surgeons to rapidly control bleeding at the surgical site, maintain clear visibility, reduce overall blood loss, and lower the risk of postoperative complications. For instance, in January 2025, according to Intuitive Surgical Inc., a US-based medical device company, OUS general surgery procedures rose by approximately 35% in 2024, following growth of around 42% in 2023. Colorectal procedures represented the largest portion of incremental volume in both years. As a result, the increasing number of surgical procedures is contributing to the expansion of the topical hemostat market.
Key players in the topical hemostat market are concentrating on developing innovative products such as hemostatic sealing patches to improve bleeding control during surgeries by offering faster, more effective, and targeted hemostasis at the wound site. A hemostatic sealing patch is a medical device made from materials like collagen or fibrin that rapidly stops bleeding by adhering to tissue and facilitating clot formation during surgery. For example, in November 2023, Ethicon, Inc., a US-based company specializing in surgical technologies, launched the ETHIZIA Hemostatic Sealing Patch, a new synthetic polymer-based adjunctive hemostat clinically shown to stop severe bleeding on internal organs quickly. In clinical trials, ETHIZIA halted bleeding within 30 seconds in 80% of patients, which is six times faster than leading fibrin sealant patches. The patch is uniquely designed to be effective on both sides and highly adaptable, allowing it to be trimmed, rolled, pulled apart, or customized for use in both open and minimally invasive surgeries. It dehydrates blood and speeds coagulation through a gelatin carrier infused with polyoxazoline polymer, forming a strong adhesive hydrogel that bonds firmly to tissue.
In May 2025, Merit Medical Systems Inc., a US-based global healthcare technology company, acquired BioLife Delaware LLC for approximately $120 million. With this acquisition, Merit seeks to strengthen its bleeding control portfolio by incorporating BioLife’s patented topical hemostatic products, such as StatSeal and WoundSeal, thereby expanding its presence in the topical hemostat market. BioLife Delaware LLC is a US-based manufacturer of hemostatic dressings developed to rapidly control bleeding and minimize complications during interventional and surgical procedures.
Major companies operating in the topical hemostat market are Pfizer Inc, Johnson And Johnson, Medtronic Plc, Medline Industries, Stryker Corporation, Baxter International, Meril Life Sciences Pvt Ltd, Teleflex Incorporated, Samyang Holdings, Integra LifeSciences, B Braun SE, Advanced Medical Solutions Group Plc, Axio Biosolutions, Marine Polymer Technologies Inc, Hangzhou Singclean Medical Products, Neo Modulus Medical Sci-Tech, Tricol Biomedical, HemCon Medical Technologies Inc, Hemostasis LLC, KATSAN Medical Devices, Zhejiang Perfectseal New Materials, Z Medica LLC, Arch Therapeutics Inc, Medcura Inc.
North America was the largest region in the topical hemostat market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the topical hemostat market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the topical hemostat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the topical hemostat market by increasing import costs of raw biomaterials and finished products, particularly affecting fibrin, collagen, and gelatin-based hemostats. Markets in North America and Europe are most impacted due to higher dependency on imported hemostats, while Asia-Pacific manufacturing hubs face fewer direct impacts. Some segments, such as locally produced cellulose and adhesive hemostats, may benefit as tariffs encourage regional sourcing and production. Overall, tariffs are driving manufacturers to optimize supply chains and invest in domestic production to maintain competitiveness.
The topical hemostat market research report is one of a series of new reports that provides topical hemostat market statistics, including topical hemostat industry global market size, regional shares, competitors with a topical hemostat market share, detailed topical hemostat market segments, market trends and opportunities, and any further data you may need to thrive in the topical hemostat industry. This topical hemostat market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A topical hemostat is a specialized medical product applied directly to a bleeding area during surgery or trauma to quickly promote clotting and control bleeding. These agents act locally by forming a physical barrier, triggering the body’s natural clotting processes, or providing a structure that supports platelet clumping and fibrin formation to stop blood flow.
The primary types of topical hemostats include fibrin, thrombin, cellulose, collagen, gelatin, adhesives, and others. Fibrin hemostats are biologically derived agents that replicate the final stages of the coagulation process by combining fibrinogen and thrombin to form a stable clot at the bleeding site. These products are distributed through channels such as direct sales, distributors, hospital pharmacies, and online platforms, and they find application in various surgeries including general, neurosurgery, vascular, and cardiovascular procedures. Key end users comprise hospitals, ambulatory surgical centers, and other healthcare facilities.
The topical hemostat market consists of sales of physical hemostats, active coagulation agents, synthetic and hemisynthetic agents, natural and plant-based agents, and chitosan-based dressings. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Topical Hemostat Market Characteristics
3. Topical Hemostat Market Supply Chain Analysis
4. Global Topical Hemostat Market Trends and Strategies
5. Topical Hemostat Market Analysis of End Use Industries
7. Global Topical Hemostat Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Topical Hemostat Total Addressable Market (TAM) Analysis for the Market
9. Topical Hemostat Market Segmentation
10. Topical Hemostat Market Regional and Country Analysis
11. Asia-Pacific Topical Hemostat Market
12. China Topical Hemostat Market
13. India Topical Hemostat Market
14. Japan Topical Hemostat Market
15. Australia Topical Hemostat Market
16. Indonesia Topical Hemostat Market
17. South Korea Topical Hemostat Market
18. Taiwan Topical Hemostat Market
19. South East Asia Topical Hemostat Market
20. Western Europe Topical Hemostat Market
21. UK Topical Hemostat Market
22. Germany Topical Hemostat Market
23. France Topical Hemostat Market
24. Italy Topical Hemostat Market
25. Spain Topical Hemostat Market
26. Eastern Europe Topical Hemostat Market
27. Russia Topical Hemostat Market
28. North America Topical Hemostat Market
29. USA Topical Hemostat Market
30. Canada Topical Hemostat Market
31. South America Topical Hemostat Market
32. Brazil Topical Hemostat Market
33. Middle East Topical Hemostat Market
34. Africa Topical Hemostat Market
36. Topical Hemostat Market Competitive Landscape and Company Profiles
37. Topical Hemostat Market Other Major and Innovative Companies
40. Topical Hemostat Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Topical Hemostat Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses topical hemostat market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for topical hemostat? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The topical hemostat market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Fibrin; Thrombin; Cellulose; Collagen; Gelatin; Adhesives; Other Types2) By Distribution Channel: Direct Sales; Distributors; Hospital Pharmacies; Online
3) By Application: General Surgery; Neurosurgery; Vascular Surgery; Cardiovascular Surgery; Other Applications
4) By End-Use: Hospitals; Ambulatory Surgical Centers; Other End-Uses
Subsegments:
1) By Fibrin: Fibrin Sealants; Fibrin Patches2) By Thrombin: Human Thrombin; Bovine Thrombin; Recombinant Thrombin
3) By Cellulose: Oxidized Regenerated Cellulose; Oxidized Non-Regenerated Cellulose; Microfibrillar Cellulose
4) By Collagen: Microfibrillar Collagen; Collagen Sponges; Collagen Fleece
5) By Gelatin: Gelatin Sponges; Gelatin Foams; Gelatin Powder
6) By Adhesives: Cyanoacrylate-Based Adhesives; Polyethylene Glycol Based Sealants; Albumin And Glutaraldehyde-Based Adhesives
7) By Other Types: Combination Hemostats; Polysaccharide-Based Hemostats; Chitosan-Based Hemostats
Companies Mentioned: Pfizer Inc; Johnson And Johnson; Medtronic Plc; Medline Industries; Stryker Corporation; Baxter International; Meril Life Sciences Pvt Ltd; Teleflex Incorporated; Samyang Holdings; Integra LifeSciences; B Braun SE; Advanced Medical Solutions Group Plc; Axio Biosolutions; Marine Polymer Technologies Inc; Hangzhou Singclean Medical Products; Neo Modulus Medical Sci-Tech; Tricol Biomedical; HemCon Medical Technologies Inc; Hemostasis LLC; KATSAN Medical Devices; Zhejiang Perfectseal New Materials; Z Medica LLC; Arch Therapeutics Inc; Medcura Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Topical Hemostat market report include:- Pfizer Inc
- Johnson And Johnson
- Medtronic Plc
- Medline Industries
- Stryker Corporation
- Baxter International
- Meril Life Sciences Pvt Ltd
- Teleflex Incorporated
- Samyang Holdings
- Integra LifeSciences
- B Braun SE
- Advanced Medical Solutions Group Plc
- Axio Biosolutions
- Marine Polymer Technologies Inc
- Hangzhou Singclean Medical Products
- Neo Modulus Medical Sci-Tech
- Tricol Biomedical
- HemCon Medical Technologies Inc
- Hemostasis LLC
- KATSAN Medical Devices
- Zhejiang Perfectseal New Materials
- Z Medica LLC
- Arch Therapeutics Inc
- Medcura Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.97 Billion |
| Forecasted Market Value ( USD | $ 8.53 Billion |
| Compound Annual Growth Rate | 9.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
